Dr Andrews gained his PhD degree from the University of Otago.  He received post-doctoral training at Yale University in the laboratory of Tamas Horvath. He is currently an Australian Research Council Future Fellow at Monash University, Australia. He has particular expertise in neuroendocrinology and the pathogenesis of Parkinson’s disease and uses sophisticated transgenic technologies to understand how mitochondrial pathways control neuronal metabolism and prevent nigral dopamine degeneration in Parkinson’s disease. He has expertise in stereology, neuroanatomy, immunohistochemistry and mouse behavior. He is an advisor to the Cure Parkinson’s Trust UK research committee headed by Dr Richard Wyse.